Provided by Tiger Fintech (Singapore) Pte. Ltd.

Doximity, Inc.

55.96
+0.04000.07%
Post-market: 55.960.00000.00%16:01 EDT
Volume:1.41M
Turnover:79.26M
Market Cap:10.51B
PE:50.41
High:57.06
Open:55.96
Low:55.73
Close:55.92
Loading ...

Doximity Co-Founder Steps Down to Advisory Role

TIPRANKS
·
14 Jun

Doximity Inc. Announces Leadership Transition as Co-Founder Dr. Nate Gross Steps Down from Day-to-Day Role, Remains as Advisor

Reuters
·
14 Jun

Deutsche Bank Remains a Hold on Dr. Martens Plc (DOCS)

TIPRANKS
·
13 Jun

Dr. Martens Directors Participate in Share Incentive Plan

TIPRANKS
·
12 Jun

Barclays Sticks to Its Hold Rating for Dr. Martens Plc (DOCS)

TIPRANKS
·
09 Jun

Berenberg Bank Sticks to Their Buy Rating for Dr. Martens Plc (DOCS)

TIPRANKS
·
09 Jun

Dr. Martens Plc Earnings Call: Mixed Results and Strategic Focus

TIPRANKS
·
08 Jun

Hold Rating on Dr. Martens Plc Amid Mixed Financial Performance and Strategic Shifts

TIPRANKS
·
05 Jun

Director Kira Scherer Wampler Reports Disposal of Doximity Inc. Common Shares

Reuters
·
04 Jun

“Demand…Will Continue to Rise”: Doximity Stock (NYSE:DOCS) Slips Despite Analyst Love

TIPRANKS
·
03 Jun

Doximity Raised to Buy From Neutral by BTIG

Dow Jones
·
02 Jun

Doximity Inc : Btig Raises to Buy From Neutral

THOMSON REUTERS
·
02 Jun

BTIG Upgrades Doximity to Buy From Neutral, Price Target is $80

MT Newswires Live
·
02 Jun

Dr. Martens Announces Total Voting Rights Update

TIPRANKS
·
30 May

Raymond James sees positive read for Doximity from Veeva trends report

TIPRANKS
·
30 May

Doximity Is Maintained at Neutral by JP Morgan

Dow Jones
·
27 May

J.P. Morgan Sticks to Its Hold Rating for Doximity (DOCS)

TIPRANKS
·
27 May

Doximity price target lowered to $60 from $63 at JPMorgan

TIPRANKS
·
27 May

Dr. Martens Plc (DOCS) Receives a Hold from Goldman Sachs

TIPRANKS
·
24 May

Doximity Inc. CEO Jeff Tangney to Present at William Blair 45th Annual Growth Stock Conference

Reuters
·
22 May